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Parathyroid hormone-dependent degradation of type II Na+/Pi
cotransporters
Abstract
Parathyroid hormone (PTH) inhibits proximal tubular brush border membrane Na+/Pi cotransport
activity; this decrease in the transport activity was found to be associated with a decrease in type II
Na+/Pi cotransporter protein content in rat brush border membranes. In the present study we
investigated the PTH-dependent regulation of the type II Na+/Pi cotransporter in opossum kidney cells,
a previously established model to study cellular mechanisms involved in the regulation of proximal
tubular Na+/Pi cotransport. We transfected opossum kidney cells with a cDNA coding for NaPi-2 (rat
renal type II Na+/Pi cotransporter). This allowed the study of PTH-dependent regulation of the
transfected NaPi-2 and of the corresponding intrinsic cotransporter (NaPi-4). The results show (i) that
the intrinsic and the transfected cotransporters are functionally (transport) and morphologically
(immunofluorescence) localized at the apical membrane, (ii) that the intrinsic as well as the transfected
Na+/Pi cotransport activities are inhibited by PTH, (iii) that PTH leads to a retrieval of both
cotransporters from the apical membrane, (iv) that both cotransporters are rapidly degraded in response
to PTH, and (v) that the reappearance/recovery of type II Na+/Pi cotransporter protein and function from
PTH inhibition requires de novo protein synthesis. These results document that PTH leads to a removal
of type II Na+/Pi cotransporters from the apical membrane and to their subsequent degradation.
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Parathyroid hormone (PTH) inhibits proximal tubu-
lar brush border membrane Na1/Pi cotransport activity;
this decrease in the transport activity was found to be
associated with a decrease in type II Na1/Pi cotrans-
porter protein content in rat brush border membranes.
In the present study we investigated the PTH-depend-
ent regulation of the type II Na1/Pi cotransporter in
opossum kidney cells, a previously established model to
study cellular mechanisms involved in the regulation of
proximal tubular Na1/Pi cotransport. We transfected
opossum kidney cells with a cDNA coding for NaPi-2 (rat
renal type II Na1/Pi cotransporter). This allowed the
study of PTH-dependent regulation of the transfected
NaPi-2 and of the corresponding intrinsic cotransporter
(NaPi-4). The results show (i) that the intrinsic and the
transfected cotransporters are functionally (transport)
and morphologically (immunofluorescence) localized at
the apical membrane, (ii) that the intrinsic as well as the
transfected Na1/Pi cotransport activities are inhibited
by PTH, (iii) that PTH leads to a retrieval of both co-
transporters from the apical membrane, (iv) that both
cotransporters are rapidly degraded in response to
PTH, and (v) that the reappearance/recovery of type II
Na1/Pi cotransporter protein and function from PTH
inhibition requires de novo protein synthesis. These re-
sults document that PTH leads to a removal of type II
Na1/Pi cotransporters from the apical membrane and to
their subsequent degradation.
Renal proximal tubular Pi reabsorption is acutely regulated
by parathyroid hormone (PTH).1 This effect involves inhibition
of the brush border membrane sodium-dependent Pi transport
and is characterized by a decrease in the maximal transport
rate (Vmax) (1, 2). Two different renal Na
1/Pi cotransporters
have been cloned, classified either as type I Na1/Pi cotrans-
porter or as type II Na1/Pi cotransporter (3–14). Both are
localized at the brush border membrane in proximal tubules.
Recent data documented that physiologically and pathophysi-
ologically altered brush border membrane Na1/Pi cotransport
involves altered brush border expression of the type II Na1/Pi
cotransporter (15–17).
In the present study we investigated the PTH-mediated reg-
ulation of the type II Na1/Pi cotransporter in opossum cells (OK
cells); these cells have recently been shown to contain such a
cotransporter (NaPi-4; Ref. 8). The validity of the opossum
kidney cell model to study proximal tubular Na1/Pi cotransport
and its regulation has been established (18–23). With respect
to PTH-dependent control of Na1/Pi cotransport activity, we
have reported that the recovery from the PTH-mediated inhi-
bition of Na1/Pi cotransport in OK cells is dependent on de novo
protein synthesis. This latter observation led to the hypothesis
that PTH might lead to the retrieval and degradation of the
transporter (27).
The aims of the present study were 2-fold: (i) to study cellu-
lar/molecular mechanisms involved in PTH-dependent control
of type II Na1/Pi cotransporters, (ii) to create by transfection an
in vitro model that also permits the study of the PTH control of
the rat type II Na1/Pi cotransporter. Obviously, the latter ap-
proach would then offer a tool to characterize the molecular
determinants involved in such regulations. A prerequisite for
this approach was the availability of antisera, permitting a
distinction between intrinsic (NaPi-4) and transfected (NaPi-2)
cotransporters.
The results obtained show that both intrinsic (NaPi-4) and
transfected type II Na1/Pi cotransporters (NaPi-2, rat) are
functionally (transport) and morphologically (immunofluores-
cence) located at the apical cell surface, are functionally inhib-
ited in response to PTH addition, are retrieved in a PTH-de-
pendent manner from the apical cell surface
(immunofluorescence), and are subsequently degraded (West-
ern blots). These data document that PTH control of the type II
Na1/Pi cotransporters involves a step of membrane retrieval
and degradation. Furthermore, the OK cell system should rep-
resent the ideal in vitro model to dissect the cellular/molecular
mechanisms participating in regulation of this proximal tubu-
lar transport function, which is crucially involved in overall Pi
homeostasis.
EXPERIMENTAL PROCEDURES
Vectors—The generation of the vectors used (pLKneo and NaPi-2/
pLKneo) has been described previously (24, 25). Both vectors code for a
geneticin (G418) resistance under a SV40 promoter. In addition, the
vector NaPi-2/pLKneo contains a cDNA coding for the rat renal type II
Na1/Pi cotransporter (NaPi-2) under a dexamethasone-inducible
promoter.
Cell Cultures and Transfections—All cell culture supplies were ob-
tained from Life Technologies, Inc. (Basel, Switzerland). Opossum kid-
ney cells (clone 3B/2) were maintained in Dulbecco’s modified Eagle’s
medium/Ham’s F-12 medium (1:1) supplemented with 10% fetal calf
serum, 22 mM NaHCO3, 20 mM Hepes, 2 mM L-glutamine, 50 IU/ml
penicillin, and 50 mg/ml streptomycin in a humidified atmosphere of 5%
CO2, 95% air at 37 °C.
Monolayers on permeable filter supports were grown on Millicell-CM
filter inserts (Millipore; 12-mm diameter, 0.45-mm pore size) coated
with a very thin film of rat tail collagen (R type, 0.5 mg/ml in 50%
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ethanol; Serva, Basel, Switzerland). Cells were seeded at approximately
1–2 3 105 cells/filter and were re-fed with fresh medium every 12 h
until reaching confluency 24 h after seeding. Transport studies were
commenced 36 h after seeding. The tightness of confluent cell monolay-
ers has been measured by resistance measurements as described pre-
viously (22).
For transfection, cells grown to a confluency of approximately 60% in
35 mm dishes (Nunc) were incubated for 16 h with 20 ml of a 1:1 mixture
of water and Lipofectin (Life Technologies) containing 10 mg of either
NaPi-2/pLKneo or the same amount of empty vector pLKneo. After-
ward, cells were trypsinized, split at a ratio of 1:30, and grown in
150-mm dishes (Nunc) in medium containing, in addition, 400 mg/ml
active geneticin. After 1–2 weeks, colonies of geneticin-resistant cells
were isolated by ring cloning, expanded, and analyzed for the expres-
sion of the NaPi-2 protein by immunoblotting (see below). For experi-
mental purposes, transfected cells were used within 10 passages. Dex-
amethasone induction was performed by an incubation with 1 mM
dexamethasone (Sigma) for 20 h (10,000-fold stock, made in ethanol).
SDS-Polyacrylamide Gel Electrophoresis and Immunoblotting—
Cells grown to confluency in 10-cm Petri dishes were incubated either
with or without dexamethasone (1 mM) for 20 h and washed twice with
TBS (0.9% NaCl, 10 mM Tris-HCl, pH 7.4). 15 ml of TBS containing 4
mM EDTA and 1 mM phenylmethylsulfonyl fluoride was added, and the
cells were scraped off the dish. The scraped cells were homogenized 5
times with a 20-ml syringe connected to a 20-gauge needle. This homo-
genate was centrifuged at 2000 rpm for 10 min at 4 °C (Sorvall centri-
fuge, SS-34 rotor). The postnuclear supernatant was centrifuged at
16,000 rpm for 40 min at 4 °C (Sorvall centrifuge, SS-34 rotor). The
pellet corresponding to a crude membrane preparation was resus-
pended in 100 ml of 50 mM mannitol, 10 mM Hepes-Tris (pH 7.2).
In experiments in which the PTH-mediated degradation of the
Na1/Pi cotransporter was investigated, the total cell homogenate was
centrifuged at 31,000 rpm (100,000 g) for 60 min at 4 °C (Sorvall
ultracentrifuge OTD 50B/T865 rotor) to ensure that all membranes
were contained within the pellet. The pellet was resuspended in 200 ml
of 50 mM mannitol, 10 mM Hepes-Tris (pH 7.2). The protein concentra-
tion was determined by the Bio-Rad protein assay. 50 mg of total protein
were used for SDS-polyacrylamide gel electrophoresis (9%) and subse-
quent transfer to nitrocellulose (Schleicher & Schuell, Inc.; 0.45 mm).
Nonspecific binding was blocked by incubating the nitrocellulose at
room temperature for 2 h in TBS (0.9% NaCl, 10 mM Tris-HCl, pH 7.4)
containing 5% nonfat dry milk and 1% Triton X-100 (Blotto-TX-100, pH
7.4). The transfected NaPi-2 protein was detected using a polyclonal
antiserum raised against the N terminus of the NaPi-2 protein (14)
(antibody dilution, 1/4000). The intrinsic NaPi-4 protein was detected
using a polyclonal antiserum raised against the C-terminal 12 amino
acids of the published NaPi-4 sequence (8) (antibody dilution, 1/2000).
Incubation with the primary antibody took place overnight at 4 °C. The
nitrocellulose was washed four times with TBS, 10% Blotto-TX-100 (pH
7.4) and incubated for 1 h with Blotto-TX-100 (pH 7.4) at room temper-
ature. Then the nitrocellulose was incubated with a 1:10,000 dilution of
an anti-rabbit IgG labeled with horseradish peroxidase (Amersham Life
Science, Inc.) in Blotto-TX-100 (pH 7.4) for 2 h at room temperature.
The nitrocellulose was washed four times with TBS, and the signals
were detected by enhanced chemiluminescense (Amersham) according
to manufacturer protocol using Kodak X-Omat AR films. For peptide
protection assays, the corresponding antigenic peptide was included at
a concentration of 100 mg/ml. Broad range SDS-polyacrylamide gel
electrophoresis molecular mass marker proteins (Bio-Rad) were run in
parallel.
Immunofluorescence—NaPi-2-transfected and untransfected 3B/2
OK cells were grown to confluency on coverslips as well as on permeable
filter supports, as described previously (22). After washing three times
with PBS containing 0.5 mM MgCl2 and 1 mM CaCl2, cells were fixed for
10 min at room temperature with PBS supplemented with 3%
paraformaldehyde, washed three times with PBS, incubated 10 min
with 20 mM L-glycine in PBS, and washed again (3 times) with PBS.
Permeabilization was performed by an incubation for 30 min with PBS
containing 0.1% saponin (PBS/saponin). After one wash with PBS/
saponin, cells were incubated with anti-NaPi-2 (14) or anti-NaPi-4 an-
tiserum at a dilution of 1:100 in PBS/saponin for 1 h at room temper-
ature and washed three times with PBS/saponin. Thereafter, the cells
were incubated with a fluorescein isothiocyanate-conjugated IgG (Da-
kopatts, Denmark) (dilution, 1:50) and phalloidine rhodamine (Calbio-
chem) (dilution, 1:50) in PBS/saponin. After incubation for 30 min in the
dark, cells were washed three times with PBS/saponin and once with
PBS. Coverslips were mounted using Dako-Glycergel (Dakopatts) plus
2.5% 1,4-diazabicyclo-[2.2.2]octane (Sigma) as a fading retardant. Im-
munofluorescence was revealed by confocal microscopy (Zeiss laser scan
microscope 310; Zeiss, Oberkochen, Germany).
Scanning Electron Microscopy—OK cell monolayers grown on colla-
gen-coated porous filter supports were prefixed with 0.25% glutaralde-
hyde in 0.16 M cacodylate buffer (pH 7.2) for 30 min at room tempera-
ture, postfixed with 2% glutaraldehyde in 0.16 M cacodylate buffer also
for 30 min at room temperature, and washed three times with 0.16 M
cacodylate buffer (pH 7.2) for 5–10 min. After that, the monolayers were
osmicated with 1% OsO4 in 0.16 M cacodylate buffer (pH 7.2) for 1 h at
37 °C, washed three times with 0.16 M cacodylate buffer, dehydrated in
an acetone series, and dried by the critical point method. The specimens
were then examined in a scanning electron microscope 505 (Philips,
Eindhoven).
Phosphate Uptake Measurements—Na1-dependent and -independent
transport of phosphate was determined in cells grown to confluency on
either plastic dishes (35 mm; Nunc) or on permeant filter supports (8
mm), as described previously (22). Briefly, uptake solutions consisted of
137 mM NaCl, 5.4 mM KCl, 2.8 mM CaCl2, 1.2 mM MgSO4, 10 mM
Hepes-Tris (pH 7.4), and 0.1 mM KH2
32PO4 (1 mCi/ml). For Na
1-inde-
pendant uptake, NaCl was replaced equimolarly by N-methyl-D-
glucaminezHCl. Routine uptake on plastic dishes was performed at
room temperature for 6 min and then stopped by washing the cells four
times with ice-cold stop solution (137 mM NaCl, 10 mM Tris-HCl, pH
7.2). Cells were solubilized with 1% Triton X-100, and radioactivity was
determined by liquid scintillation. Transport rates are expressed as
nmol of Pi taken up/mg of total cellular protein, which was determined
by the Bio-Rad protein assay.
For transport assays on permeant filter supports, growth medium
was aspirated, and both sides of the monolayer were gently rinsed twice
in substrate-free uptake solution. Filter insert monolayers were then
placed in a 24-well culture plate (Nunclon) for uptake measurements.
Substrate-free uptake solution (500 ml) was added to the appropriate
filter insert compartment, and N-methyl-D-glucaminezHCl-uptake solu-
tion was added to the opposite compartment. Transport was initiated by
mixing 50 ml of the same uptake solution containing an 11-fold concen-
tration of the desired radioactive substrate to the uptake solution
already present in the filter insert compartment. Uptake was stopped
as described above. Nonspecific binding (blanks) was assessed meas-
uring zero time uptake in N-methyl-D-glucaminezHCl-uptake solution
by starting uptake and immediately aspirating the uptake solution.
Nonspecific binding was ,10% that of radioactivity associated with any
experimental point. Total radioactivity incorporated into the monolayer
was measured by liquid scintillation counting of the whole filter insert.
PTH Incubation/Treatment with Cycloheximide—Incubation of OK
cells with PTH has been described previously (22). Treatment of OK
cells with cycloheximide to prevent protein synthesis has also been
described previously (27).
Presentation of the Results—Statistical results are expressed as
mean 6 S.E. for three dishes. Significance was accepted at p , 0.05.
Experiments were repeated at least twice, and one representative ex-
periment was choosen for presentation. The results presented concern-
ing the transfected NaPi-2 were obtained with one single clone of
NaPi-2-transfected 3B/2 OK cells. Qualitatively, the same results were
obtained with two other clones of stably NaPi-2-transfected 3B/2 OK
cells.
RESULTS
Characterization of OK Cells Stably Transfected with the Rat
Renal Type II Na1/Pi Cotransporter (NaPi-2)—To study trans-
port function, transfected OK cells were grown to confluency on
plastic Petri dishes and exposed to 1 mM dexamethasone for
20 h to induce the expression of the transfected NaPi-2. As
illustrated in Fig. 1, induction of NaPi-2 expression in trans-
fected OK cells by dexamethasone led to an approximately
2-fold stimulation of the Na1-dependent Pi transport, whereas
dexamethasone had no significant effect on the Na1/Pi cotrans-
port activity in empty vector-transfected and in untransfected
OK cells. Furthermore, dexamethasone had no effect in any of
the tested cell lines on the Na1-independent Pi transport (Fig.
1 and data not shown). Corresponding experiments have been
carried out with NaPi-2-transfected OK cells grown to conflu-
ency on collagen-coated porous filter supports. By measuring
the Pi transport at the apical and basolateral membrane sep-
arately in induced and noninduced NaPi-2-transfected OK
cells, it was found that the additional Pi uptake, as observed in
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cells grown on Petri dishes (Fig. 1), is entirely restricted to the
apical membrane (data not shown).
Transfected OK cells were also analyzed for expression of the
NaPi-2 protein. Induction of NaPi-2-transfected OK cells by
dexamethasone (1 mM, 20 h) led to the expression of a protein
with an apparent molecular mass of 95–120 kDa (Fig. 2). An
excess of the corresponding antigenic peptide (100 mg/ml) pre-
vented the appearance of this band completely. The band seen
above the NaPi-2 protein is unspecific: it is neither induced by
dexamethasone nor protected by the antigenic peptide (Fig.
2A). The intrinsic type II transporter protein (NaPi-4) was
detected by the use of an antiserum directed against the C
terminus of NaPi-4. Fig. 2B shows the NaPi-4-specific signal
detected with membranes obtained from untransfected OK
cells. Specificity of the anti-NaPi-4 antiserum was established
by peptide protection assay with the corresponding antigenic
peptide (100 mg/ml; Fig. 2B). Comparing Fig. 2A with Fig. 2B
shows that the intrinsic NaPi-4 and the transfected NaPi-2
have approximately the same molecular mass (95–120 kDa).
Furthermore it is seen that the anti-NaPi-2 antiserum does not
cross-react with the intrinsic NaPi-4 (Fig. 2A, transfected cells
in the absence of dexamethasone).
Expression of the type II transporter was also analyzed by
immunofluorescence. Immunofluorescence pictures obtained
by confocal microscopy showed that both the intrinsic NaPi-4
(Fig. 3A) and the transfected NaPi-2 (Fig. 3B) are localized at
the apical membrane within distinct clusters of a diameter of
about 1–2 mm, whereas no type II Na1/Pi cotransporter-specific
staining was seen at the basolateral membrane. The immuno-
histochemical staining of the transfected NaPi-2 as well as of
the intrinsic NaPi-4 could be specifically abolished by the cor-
responding antigenic peptide (100 mg/ml; data not shown). In
Figs. 3A and 3B, the parallel staining for b-actin (a component
of the microvillar cytoskeleton) is shown. It is apparent that
NaPi-4-specific (Fig. 3A) and NaPi-2-specific (Fig. 3B) staining
on the apical cell surface coincides with the b-actin staining. In
addition to the above apical staining, b-actin is also present at
the basolateral cell surfaces (Fig. 3A and 3B). Visualization of
the apical surface of OK cells by scanning electron microscopy
showed that microvilli are expressed at the apical surface,
forming distinct clusters (Fig. 3C); the diameter of the clusters
FIG. 2. Expression of the NaPi-2 protein in transfected OK
cells, and expression of the intrinsic NaPi-4 protein in untrans-
fected OK cells. NaPi-2-transfected (A) and untransfected OK cells (B)
were grown to confluency on Petri dishes and, where indicated (DEX,
1), were treated with dexamethasone (1 mM, 20 h). Crude membrane
preparations were analyzed by immunoblotting using an anti-NaPi-2
antiserum (A) or an anti-NaPi-4 antiserum (B). Incubation with pri-
mary antibody was performed in the absence (Peptide, 2) or in the
presence (Peptide, 1) of the corresponding antigenic peptide (peptide
protection). The staining seen above the 116-kDa region in the Fig. 2A
is unspecific (see text).
FIG. 3. The intrinsic NaPi-4 protein and the transfected NaPi-2
protein are expressed at the apical membrane of OK cells within
microvilli. NaPi-2-transfected and untransfected OK cells were grown
to confluency on glass coverslips and further processed for immunoflu-
orescence (A and B). Each set of pictures obtained by confocal micros-
copy contains an apically located focal plane (xy-plane) and cross-sec-
tions corresponding to xz and yz planes. White lines in the xy plane
indicate the different sections along the z axis. White lines in the xz and
yz planes indicate the location of the xy plane. A and B show immuno-
histochemical double stainings of b-actin and NaPi-4 in untransfected
OK cells (A) and b-actin and NaPi-2 in dexamethasone-induced NaPi-
2-transfected OK cells (B). It is seen that b-actin and NaPi-4 and b-actin
and NaPi-2 colocalize within distinct clusters at the apical membrane.
Scanning electron microscopy demonstrates the presence of clustered
microvilli at the apical surface of OK cells (C). The diameter of these
clustered microvilli corresponds well with the diameter of the distinct
clusters at the apical membrane seen in the immunofluorescence pic-
tures in Fig. 3, A and B.
FIG. 1. Dexamethasone-induced expression of Na1/Pi cotrans-
port in NaPi-2-transfected OK cells. OK cells (NaPi-2-transfected,
empty vector-transfected, and untransfected OK cells) were grown to
confluency on plastic Petri dishes and, where indicated (DEX, 1), were
exposed to 1 mM dexamethasone for 20 h. Dexamethasone-induced
NaPi-2-transfected OK cells showed an approximately 2-fold stimula-
tion of the Na1/Pi cotransport activity, whereas dexamethasone had no
significant effect on the intrinsic Na1/Pi cotransport in empty vector-
transfected and untransfected OK cells.
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corresponds well with the diameter of the clusters seen by
immunofluorescence double staining for b-actin and the corre-
sponding type II Na1/Pi cotransporter. Therefore the data
given in Fig. 3 (A–C) documents that intrinsic and transfected
type II Na1/Pi cotransporters are predominantly expressed at
the apical cell surface (most likely within microvilli).
PTH-dependent Regulation of Type II Na1/Pi Cotransport-
ers—Fig. 4 summarizes the effect of PTH (1028 M; 4 h) on the
Na1-dependent Pi transport in NaPi-2-transfected OK cells as
well as in untransfected OK cells. PTH inhibited the Na1-de-
pendent Pi transport activity in control cells by about 60%. A
similar inhibitory effect of PTH was observed in NaPi-2-trans-
fected cells that were not treated with dexamethasone. In cells
expressing the NaPi-2 transporter (induced by dexametha-
sone), PTH also inhibited the additionally expressed Na1/Pi
cotransport activity. Interestingly, the residual transport ac-
tivity after PTH treatment was similar in all cells tested. This
latter observation is in agreement with earlier studies (21, 27)
demonstrating a PTH-insensitive Na1/Pi cotransport activity
in OK cells.
The effect of PTH on the type II Na1/Pi cotransporter protein
content was investigated by immunoblotting. Fig. 5 shows that
incubating OK cells for increasing times with PTH (1028 M)
leads to a time-dependent decrease of NaPi-4 and NaPi-2 pro-
tein expressed in OK cells. We conclude that the whole protein
was degraded due to PTH action and that both transfected
(NaPi-2) and intrinsic transporter (NaPi-4) behave very simi-
lar, i.e. are degraded. The finding that PTH leads to the deg-
radation of the type II Na1/Pi cotransporter is in agreement
with our previous observation that the recovery of the Na1/Pi
cotransport after PTH-mediated inhibition is dependent on de
novo protein synthesis (27, 28). To evaluate whether the recov-
ery of the transport was due to de novo synthesis of type II
Na1/Pi cotransporter, cell monolayers were exposed to 10
28 M
PTH for 4 h, PTH was removed, and cell monolayers were
incubated with normal medium in the presence or absence of 20
mM cycloheximide for 2 or 4 h. The results presented in Fig. 6
show that the reappearance of the transporter is dependent on
de novo protein synthesis. It is also seen that 4 h after PTH
removal, the reappearance of the transporter is not completed.
Parallel measurements of the Na1/Pi cotransport showed that
after 4 h of PTH removal, the recovery of the Na1/Pi cotrans-
port is also incomplete. This is in agreement with our previous
observation that complete recovery of Na1/Pi cotransport from
PTH inhibition takes about 10–12 h (28).
The retrieval of the intrinsic (NaPi-4) and the transfected
cotransporter (NaPi-2) upon addition of PTH could also be
documented by immunofluorescence. Consistent with the data
presented above (Figs. 4–6), we found that incubating OK cells
with PTH (1028 M) leads to a time-dependent decrease of NaPi-
4-dependent immunofluorescence and NaPi-2-dependent im-
munofluorescence at the apical membrane of OK cells (data not
shown). After 4 h of PTH treatment (1028 M), the Na1/Pi co-
transporter type II-specific immunofluorescence staining in un-
transfected (Fig. 7A) and NaPi-2-transfected OK cells (Fig. 7B)
was virtually absent. Corresponding immunofluorescence pic-
tures (double immunofluorescence) stained for b-actin clearly
showed that under these conditions the microvilli were still
present at the apical surface of OK cells. With the aim to detect
the retrieved Na1/Pi cotransporters within intracellular vesi-
cles, we have treated OK cells for increasing times with PTH (0,
0.5, 1, 2, and 4 h; data not shown). As mentioned above, we
observed a time-dependent decrease of the NaPi-4-specific
staining and NaPi-2-specific staining at the apical surface.
However, we were not able to detect a significant amount of
NaPi-4 protein or NaPi-2 protein within intracellular vesicles
at any time points (data not shown). As already suggested by
the experiments presented in Fig. 5, a delay between a PTH-
dependent membrane retrieval and intracellular degradation
seems to be absent or minimal.
FIG. 4. Parathyroid hormone (1028 M h) leads to the inhibition
of the intrinsic and the transfection-mediated Na1/Pi cotrans-
port activity in transfected OK cells. Na1/Pi cotransport was deter-
mined in cells grown to confluency on Petri dishes. Confluent NaPi-2-
transfected and untransfected 3B/2 OK cells were treated with
dexamethasone (DEX, 1 mM, 20 h) and/or PTH (1028 M, 4 h), respec-
tively, where indicated.
FIG. 5. Parathyroid hormone (1028 M) leads to the disappear-
ance of the NaPi-4-specific (A) and NaPi-2-specific (B) staining
on immunoblots. Untransfected and NaPi-2-transfected OK cells were
grown to confluency on Petri dishes, and NaPi-2-transfected OK cells
were induced by dexamethasone (1 mM, 20 h). OK cells were treated
with PTH (1028 M) for various lengths of time (0, 1, 2, and 4h) and
analyzed by immunoblotting for the expression of NaPi-4- and NaPi-2
proteins.
FIG. 6. Reappearance of the NaPi-4 protein after PTH removal
requires de novo protein synthesis. Confluent OK cell monolayers
were incubated for 4 h with PTH (1028 M). Then the culture medium
was removed, cells were repeatedly washed with normal medium to
remove the PTH, and cells then incubated with medium with or without
20 mM cycloheximide for 2 and 4 h, respectively. The above Western blot
shows clearly that the reappearance of the transporter is dependent on
de novo protein synthesis.
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Previous studies on rats have suggested that inhibition of
Na1/Pi cotransport in renal proximal tubules by PTH involves
a retrieval of the type II Na1/Pi cotransporter (NaPi-2) from the
brush border membrane (15). The recent cloning of the type II
Na1/Pi cotransporter of OK cells (NaPi-4; Ref. 8) and the obvi-
ous limitations of an in vivo system to study molecular mech-
anisms prompted us to investigate the regulation of this trans-
porter by PTH in OK cells. OK cells are a renal epithelial cell
line that has been used successfully to investigate mechanisms
involved in the control of proximal tubular Na1/Pi cotransport
by PTH (21, 27). In the present study, we stably transfected OK
cells with a cDNA coding for the rat type II Na1/Pi cotrans-
porter (NaPi-2) and investigated whether similar mechanisms
are involved in the PTH-mediated regulation of the intrinsic
(NaPi-4) and the transfected transporters (NaPi-2).
On immunoblots, appearance of the transfected (NaPi-2) and
the intrinsic (NaPi-4) cotransporter proteins resembled each
other closely. The broad staining pattern (95–120 kDa) of these
transporters likely represents different degrees of glycosyla-
tion, which for the NaPi-2 protein, has recently been demon-
strated (29). The expression of the rat type II Na1/Pi cotrans-
porter was also demonstrated by transport experiments.
Dexamethasone-induced NaPi-2-transfected OK cells exhibited
an approximately 2-fold-stimulated transport activity com-
pared with uninduced NaPi-2-transfected or control cells (un-
transfected and empty vector-transfected). Immunofluorescence
experiments demonstrated an exclusive apical localization for
both Na1/Pi cotransporters (intrinsic and transfected), that, in
the case of the intrinsic NaPi-4, is in agreement with earlier
transport studies performed with OK cells grown on permeant
filter supports (22). Furthermore, immunofluorescence demon-
strated a concentration of the intrinsic as well as of the trans-
fected Na1/Pi cotransporters within clustered microvillar
structures. It is suggested that such a distinct concentration of
the Na1/Pi cotransporters within the microvilli may be due to a
yet unknown interaction of these transporters with compo-
nents of the microvillar cytoskeleton. Clearly no immuno-
staining related to these transporters was detected in the ba-
solateral membrane, suggesting a specific apical sorting
mechanism for the type II Na1/Pi cotransporters in OK cells. In
contrast, we recently demonstrated that the NaPi-2, when
transfected into Madin-Darby canine kidney cells, is expressed
to equal amounts at the apical and basolateral membrane (25).
The observed different sorting behavior of the same transporter
in two different cell lines indicates that not only molecular
determinants are decisive for a polarized sorting but that also
the cellular context is of importance. This has also been docu-
mented for other proteins and cell systems. For example, it has
been shown that aquaporin-2, when transfected into LLC-PK1
cells, is, upon cAMP stimulation, inserted into the basolateral
membrane rather than into the apical membrane as suggested
from studies on native renal epithelia (30).
In previous studies it has been demonstrated that the intrin-
sic apical Na1/Pi cotransport activity in OK cells is inhibited by
PTH (21, 27). In the present study we extended this observa-
tion by showing that the inhibition of the Na1/Pi cotransport by
PTH in OK cells is paralleled by the disappearance of the
apical, Na1/Pi cotransporter-specific immunofluorescence
staining within the microvilli. It is also shown that PTH leads
to the degradation of the type II Na1/Pi cotransporter in OK
cells. This finding is in agreement with our earlier observation
demonstrating that the recovery of Na1/Pi cotransport activity
from PTH inhibition in OK cells is dependent on de novo
protein synthesis. Correspondingly, we found that the recovery
of Na1/Pi cotransport activity from PTH inhibition was paral-
FIG. 7. Parathyroid hormone (1028 M, 4 h) leads to the disap-
pearance of the NaPi-2- and NaPi-4-specific immunohistochem-
ical staining within the microvilli at the apical membrane. Un-
transfected and NaPi-2-transfected OK cells were grown to confluency
on glass coverslips. NaPi-2-transfected OK cells were induced by dexa-
methasone (1 mM, 20 h), and untransfected and induced transfected OK
cells were treated with PTH (1028 M, 4 h) where indicated. Each set of
pictures obtained by confocal microscopy contains an apically located
focal plane (xy-plane) and cross-sections corresponding to xz and yz
planes. White lines in the xy plane indicate the different sections along
the z axis, whereas the white lines in the xz and yz planes indicate the
location of the xy plane. It is seen that after 4 h of PTH treatment, the
NaPi-4-specific (A) and NaPi-2-specific (B) staining within the microvilli
has almost completely disappeared, whereas the microvilli are still
present at the apical membrane (see b-actin stainings).
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leled on immunoblots by the reappearance of the type II Na1/Pi
cotransporter protein. In the presence of cycloheximide, there
was neither a recovery of transport activity nor a reappearance
of the specific transporter protein. As documented by immuno-
blots and by immunohistochemical studies presented in this
paper, PTH leads to an almost complete retrieval and degra-
dation of the type II Na1/Pi cotransporter (Figs. 5 and 7).
However, even after prolonged exposures to PTH, a “refractory”
residual Na1/Pi cotransport activity is observed (Fig. 4 and Ref.
21). This implies that this residual activity (;40% of total
transport activity) is not related to the type II Na1/Pi cotrans-
porter but could be associated with, for example, the type I
transporter. Such conclusions are also valid for the Na1/Pi
cotransport activity in rat brush border membranes; 2 h of PTH
treatment leads to a much higher reduction of the NaPi-2
protein compared with the reduction in Na1/Pi cotransport
activity (15).
The present study clearly indicates that the regulation of the
type II Na1/Pi cotransporter in renal proximal tubules and in
OK cells is very similar. One apparent difference exists: after
PTH treatment of OK cells for various lengths (0.5, 1, 2 , and
4 h) we were not able to detect a significant transient intracel-
lular staining specific for the type II Na1/Pi cotransporter. In
rat proximal tubules, the degradation of the NaPi-2 protein
seems to be delayed (compared with the OK cell system), per-
mitting a visualization of an increased intracellular NaPi-2
protein content after short (15 min to 1 h) but not after pro-
longed treatments with PTH (15). Despite this difference, the
similarities in the regulation of this transporter by PTH in OK
cells and in rat renal proximal tubules are evident. Further-
more, in this report we demonstrated that the transfected
(NaPi-2) and intrinsic type II Na
1/Pi cotransporters (NaPi-4)
are regulated in OK cells in the same way by PTH. OK cells are
therefore a physiologically relevant in vitro system for the
study of the regulation of the type II Na1/Pi cotransporter type
II. They are a useful tool to dissect the molecular/cellular
mechanisms involved in the PTH-mediated internalization and
subsequent degradation of the transporter. Although it is
tempting to assume a final breakdown of these Na1/Pi cotrans-
porters within lysosomes, the mechanisms involved in inter-
nalization, trafficking, and subsequent degradation are com-
pletely unknown.
In summary, the present study shows (i) that the intrinsic
(NaPi-4) and the transfected rat type II Na
1/Pi cotransporter
(NaPi-2) are functionally and morphologically localized at the
apical membrane, (ii) that the intrinsic as well as the transfec-
tion-mediated (NaPi-2) Na
1/Pi cotransport activities are inhib-
ited by PTH, (iii) that PTH leads to the disappearance of both
cotransporters from the apical membrane, and (iv) that both
cotransporters are rapidly degraded in response to PTH. These
results suggest that PTH leads to the endocytosis of the type II
Na1/Pi cotransporters from the apical membrane and to their
subsequent degradation, thereby leading to the down-regula-
tion of the Na1/Pi cotransport.
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